resp Flashcards
causes of pleural effusion
exudate (protein > 35g/dl): infection (pneumonia), inflammation (SLE, rheumatoid arthritis), malignancy (lung cancer, mets)
transudate (protein < 25g/dl): cardiac, liver, renal failure
causes of ILD
idiopathic pulmonary fibrosis
occupational / environmental: extrinsic allergic alveolitis / pneumoconiosis
drugs: methotrexate, amiodarone
inflammatory: SLE, RA, sarcoidosis, ank spond, systemic sclerosis
other: radiation
ILD investigations
bloods: FBC, CRP/ESR,
serology: RF, ANA, anti-CCP, anti-Jo
lung function tests (restrictive pattern)
CXR (initial)
high-res CT → honeycombing
bronchoscopy + biopsy (diagnostic)
definition of COPD
emphysema + chronic bronchitis
emphysema = enlargement of alveolar spaces
chronic bronchitis = chronic productive cough for at least 3mths/year for at least 2 years
signs of hyperexpansion
reduced cricosternal distances (normal = 3 fingers) tracheal tug barrel chest reduced chest expansion loss of cardiac dullness displaced liver edge
signs on examination for COPD
hyperexpansion hyperresonance reduced breath sounds + vocal resonance coarse crackles expiratory wheeze
causes type 1 resp failure
ventilation perfusion mismatch: pneumonia PE pulmonary oedema asthma ARDS
causes type 2 resp failure
resp disease: COPD, asthma, pneumonia, obstructive sleep apnoea
reduced resp drive: sedatives, CNS tumour / trauma
neuromuscular disease: guillain-barre, myasthenia gravis
thoracic wall disease: flail chest, kyphoscoliosis
pulmonary embolism ECG findings
S1Q3T3
deep S waves in lead I
deep Q waves in lead III
inverted T waves in lead III
management suspected pulmonary embolism
Well’s score:
4 or less = PE unlikely → D-dimer → immediate CTPA + admission if +ve
5 or more = PE likely → admission + immediate CTPA
management confirmed pulmonary embolism
- LMWH (tinzaparin 175units/kg once daily SC) / fondaparinux for > 5 days / until INR > 2 for > 24hrs
for 6mths for pts w active cancer - start warfarin within 24hrs
continue for at least 3mths and reassess whether should be continued
continue for >3mths if unprovoked PE - thrombolysis for massive PE w haemodynamic instability: tPa, streptokinase
management stable COPD
- short acting bronchodilator: SABA (salb) / SAMA (ipratropium)
- long acting bronchodilator: LABA (salmeterol), LAMA (tiotropium)
- inhaled corticosteroid (combined inhalers if poss)
long-term oxygen therapy
surg: lung volume reduction surg / transplant
- inhaled corticosteroid (combined inhalers if poss)
management acute COPD
ABCDE
- neb salb / ipratropium
- oxygen if sats < 90 (aim for 88-92%) via venturi
- oral steroids 5 days
- NIV (BiPAP) if respiratory insufficiency
- antibiotics if infective exacerbation
management acute asthma
ABCDE oxygen: high-flow 15L via non-rebreathe mask neb 5mg salb (oxygen-driven / via spacer) oral pred 40mg (5 days) neb ipratropium IV magnesium sulphate IV aminophylline intubation + ventilation
management stable asthma
- PRN inhaled SABA (salb)
- BD inhaled low-dose CS (beclamethasone)
- inhaled LABA (salmeterol)
if not effective consider: increased steroid dose, LTRA (montelukast), SR theophylline, oral beta-agonist
- inhaled LABA (salmeterol)
- daily oral steroids
indications for NIV (BiPAP)
COPD w respiratory acidosis 7.25-7.35
type 2 respiratory failure (neuromuscular disease or chest wall deformities)
failure of CPAP for pulmonary oedema
indications for CPAP
chronic severe obstructive sleep apnoea
type 1 respiratory failure e.g. acute pulmonary oedema
ILD management
cons: MDT approach, smoking cessation, pulmonary rehabilitation
med: anti-fibrotic drugs e.g. pirfenidone, nintedanib
steroids (exacerbation fo Sx)
LTOT
surgery: lung transplant (curative)
signs on examination ILD
clubbing
fine end-inspiratory crepitations